Evidence of Plasmodium vivax circulation in western and eastern regions of Senegal: implications for malaria control.
Plasmodium vivax
Diagnosis
Senegal
Targeted sequencing
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
16 May 2024
16 May 2024
Historique:
received:
02
11
2023
accepted:
04
04
2024
medline:
16
5
2024
pubmed:
16
5
2024
entrez:
15
5
2024
Statut:
epublish
Résumé
Malaria elimination in Senegal requires accurate diagnosis of all Plasmodium species. Plasmodium falciparum is the most prevalent species in Senegal, although Plasmodium malariae, Plasmodium ovale, and recently Plasmodium vivax have also been reported. Nonetheless, most malaria control tools, such as Histidine Rich Protein 2 rapid diagnosis test (PfHRP2-RDT,) can only diagnose P. falciparum. Thus, PfHRP2-RDT misses non-falciparum species and P. falciparum infections that fall below the limit of detection. These limitations can be addressed using highly sensitive Next Generation Sequencing (NGS). This study assesses the burden of the four different Plasmodium species in western and eastern regions of Senegal using targeted PCR amplicon sequencing. Three thousand samples from symptomatic and asymptomatic individuals in 2021 from three sites in Senegal (Sessene, Diourbel region; Parcelles Assainies, Kaolack region; Gabou, Tambacounda region) were collected. All samples were tested using PfHRP2-RDT and photoinduced electron transfer polymerase chain reaction (PET-PCR), which detects all Plasmodium species. Targeted sequencing of the nuclear 18S rRNA and the mitochondrial cytochrome B genes was performed on PET-PCR positive samples. Malaria prevalence by PfHRP2-RDT showed 9.4% (94/1000) and 0.2% (2/1000) in Diourbel (DBL) and Kaolack (KL), respectively. In Tambacounda (TAM) patients who had malaria symptoms and had a negative PfHRP2-RDT were enrolled. The PET-PCR had a positivity rate of 23.5% (295/1255) overall. The PET-PCR positivity rate was 37.6%, 12.3%, and 22.8% in Diourbel, Kaolack, and Tambacounda, respectively. Successful sequencing of 121/295 positive samples detected P. falciparum (93%), P. vivax (2.6%), P. malariae (4.4%), and P. ovale wallikeri (0.9%). Plasmodium vivax was co-identified with P. falciparum in thirteen samples. Sequencing also detected two PfHRP2-RDT-negative mono-infections of P. vivax in Tambacounda and Kaolack. The findings demonstrate the circulation of P. vivax in western and eastern Senegal, highlighting the need for improved malaria control strategies and accurate diagnostic tools to better understand the prevalence of non-falciparum species countrywide.
Sections du résumé
BACKGROUND
BACKGROUND
Malaria elimination in Senegal requires accurate diagnosis of all Plasmodium species. Plasmodium falciparum is the most prevalent species in Senegal, although Plasmodium malariae, Plasmodium ovale, and recently Plasmodium vivax have also been reported. Nonetheless, most malaria control tools, such as Histidine Rich Protein 2 rapid diagnosis test (PfHRP2-RDT,) can only diagnose P. falciparum. Thus, PfHRP2-RDT misses non-falciparum species and P. falciparum infections that fall below the limit of detection. These limitations can be addressed using highly sensitive Next Generation Sequencing (NGS). This study assesses the burden of the four different Plasmodium species in western and eastern regions of Senegal using targeted PCR amplicon sequencing.
METHODS
METHODS
Three thousand samples from symptomatic and asymptomatic individuals in 2021 from three sites in Senegal (Sessene, Diourbel region; Parcelles Assainies, Kaolack region; Gabou, Tambacounda region) were collected. All samples were tested using PfHRP2-RDT and photoinduced electron transfer polymerase chain reaction (PET-PCR), which detects all Plasmodium species. Targeted sequencing of the nuclear 18S rRNA and the mitochondrial cytochrome B genes was performed on PET-PCR positive samples.
RESULTS
RESULTS
Malaria prevalence by PfHRP2-RDT showed 9.4% (94/1000) and 0.2% (2/1000) in Diourbel (DBL) and Kaolack (KL), respectively. In Tambacounda (TAM) patients who had malaria symptoms and had a negative PfHRP2-RDT were enrolled. The PET-PCR had a positivity rate of 23.5% (295/1255) overall. The PET-PCR positivity rate was 37.6%, 12.3%, and 22.8% in Diourbel, Kaolack, and Tambacounda, respectively. Successful sequencing of 121/295 positive samples detected P. falciparum (93%), P. vivax (2.6%), P. malariae (4.4%), and P. ovale wallikeri (0.9%). Plasmodium vivax was co-identified with P. falciparum in thirteen samples. Sequencing also detected two PfHRP2-RDT-negative mono-infections of P. vivax in Tambacounda and Kaolack.
CONCLUSION
CONCLUSIONS
The findings demonstrate the circulation of P. vivax in western and eastern Senegal, highlighting the need for improved malaria control strategies and accurate diagnostic tools to better understand the prevalence of non-falciparum species countrywide.
Identifiants
pubmed: 38750583
doi: 10.1186/s12936-024-04932-z
pii: 10.1186/s12936-024-04932-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
149Subventions
Organisme : Crick African Network
ID : UK's Global Challenges Research Fund (MR/P028071/1), and by the Francis Crick Institute which receives its core funding from Cancer Research UK (CC2079, CC0199), the UK Medical Research Council (CC2079, CC0199), and the Wellcome Trust (CC2079, CC0199)
Informations de copyright
© 2024. The Author(s).
Références
WHO. Global technical strategy for malaria 2016–2030, 2021 update. Geneva: World Health Organization; 2021.
Stresman G, Whittaker C, Slater HC, Bousema T, Cook J. Quantifying Plasmodium falciparum infections clustering within households to inform household-based intervention strategies for malaria control programs: an observational study and meta-analysis from 41 malaria-endemic countries. PLoS Med. 2020;17: e1003370.
doi: 10.1371/journal.pmed.1003370
pubmed: 33119589
pmcid: 7595326
Doderer-Lang C, Atchade PS, Meckert L, Haar E, Perrotey S, Filisetti D, et al. The ears of the African elephant: unexpected high seroprevalence of Plasmodium ovale and Plasmodium malariae in healthy populations in Western Africa. Malar J. 2014;13:240.
doi: 10.1186/1475-2875-13-240
pubmed: 24946685
pmcid: 4071337
Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, et al. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis. 2010;4: e774.
doi: 10.1371/journal.pntd.0000774
pubmed: 20689816
pmcid: 2914753
White MT, Karl S, Battle KE, Hay SI, Mueller I, Ghani AC. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission. ELife. 2014;3: e04692.
doi: 10.7554/eLife.04692
pubmed: 25406065
pmcid: 4270097
Robinson LJ, Wampfler R, Betuela I, Karl S, White MT, Li Wai Suen CSN, et al. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomized placebo controlled trial and mathematical model. PLoS Med. 2015;12: e1001891.
doi: 10.1371/journal.pmed.1001891
pubmed: 26505753
pmcid: 4624431
https://planificateur.a-contresens.net/afrique/senegal/fatick/diourbel_sine/2252307.html
https://planificateur.a-contresens.net/afrique/senegal/kaolack/kaolack/2250805.html
https://planificateur.a-contresens.net/afrique/senegal/tambacounda/tambacounda/2244991.html
Lucchi NW, Karell MA, Journel I, Rogier E, Goldman I, Ljolje D, et al. PETPCR method for the molecular detection of malaria parasites in a national malaria surveillance study in Haiti, 2011. Malar J. 2014;13:462.
doi: 10.1186/1475-2875-13-462
pubmed: 25428550
pmcid: 4289323
Lima de GFMC, Lucchi NW, Silva-Flannery L, Macedo-de-Oliveira A, Hristov AD, Inoue J, et al. Still searching for a suitable molecular test to detect hidden Plasmodium infection: a proposal for blood donor screening in Brazil. PLoS One. 2016;11: e0150391.
doi: 10.1371/journal.pone.0150391
Lalremruata A, Jeyaraj S, Engleitner T, Joanny F, Lang A, Bélard S, et al. Species and genotype diversity of Plasmodium in malaria patients from Gabon analysed by next generation sequencing. Malar J. 2017;16:398.
doi: 10.1186/s12936-017-2044-0
pubmed: 28974215
pmcid: 5627438
arXiv:1303.3997v2 [q-bio.GN] https://doi.org/10.48550/arXiv.1303.3997
Niang M, Sane R, Sow A, Sadio BD, Chy S, Legrand E, et al. Asymptomatic Plasmodium vivax infections among Duffy-negative population in Kedougou, Senegal. Trop Med Health. 2018;46:45.
doi: 10.1186/s41182-018-0128-3
pubmed: 30618490
pmcid: 6311047
Niang M, Diop F, Niang O, Sadio BD, Sow A, Faye O, et al. Unexpected high circulation of Plasmodium vivax in asymptomatic children from Kédougou, southeastern Senegal. Malar J. 2017;16:497.
Niang M, Diop F, Niang O, Sadio BD, Sow A, Faye O, et al. Unexpected high circulation of Plasmodium vivax in asymptomatic children from Kédougou, southeastern Senegal. Malar J. 2017;16:497.
doi: 10.1186/s12936-017-2146-8
pubmed: 29284488
pmcid: 5747145
Daniels RF, Deme AB, Gomis JF, Dieye B, Durfee K, Thwing JI, et al. Evidence of non-Plasmodium falciparum malaria infection in Kédougou, Sénégal. Malar J. 2017;16:9.
doi: 10.1186/s12936-016-1661-3
pubmed: 28049489
pmcid: 5209815
Badiane AS, Ndiaye T, Thiaw AB, Deme AB, Diallo MA, Seck MC, et al. High prevalence of asymptomatic Plasmodium infection in Bandafassi, South-East Senegal. Malar J. 2021;20:218.
doi: 10.1186/s12936-021-03746-7
pubmed: 33980241
pmcid: 8117620
Seck MC, Thwing J, Badiane AS, Rogier E, Fall FB, Ndiaye PI, et al. Analysis of anti-Plasmodium IgG profiles among Fulani nomadic pastoralists in northern Senegal to assess malaria exposure. Malar J. 2020;19:15.
doi: 10.1186/s12936-020-3114-2
pubmed: 31931834
pmcid: 6958760
Baird JK. African Plasmodium vivax malaria improbably rare or benign. Trends Parasitol. 2022;38:683–96.
doi: 10.1016/j.pt.2022.05.006
pubmed: 35667992
Twohig KA, Pfeffer DA, Baird JK, Price RN, Zimmerman PA, Hay SI, et al. Growing evidence of Plasmodium vivax across malaria-endemic Africa. PLoS Negl Trop Dis. 2019;13: e0007140.
doi: 10.1371/journal.pntd.0007140
pubmed: 30703083
pmcid: 6372205
Ba H, Duffy CW, Ahouidi AD, Deh YB, Diallo MY, Tandia A, et al. Widespread distribution of Plasmodium vivax malaria in Mauritania on the interface of the Maghreb and West Africa. Malar J. 2016;15:80.
doi: 10.1186/s12936-016-1118-8
pubmed: 26861780
pmcid: 4748559
Bernabeu M, Gomez-Perez GP, Sissoko S, Niambélé MB, Haibala AA, Sanz A, et al. Plasmodium vivax malaria in Mali: a study from three different regions. Malar J. 2012;11:405.
doi: 10.1186/1475-2875-11-405
pubmed: 23217064
pmcid: 3547733
Niangaly A, Karthigayan G, Amed O, Coulibaly D, Sá JM, Adams M, et al. Plasmodium vivax Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara. Mali Am J Trop Med Hyg. 2017;97:744–52.
doi: 10.4269/ajtmh.17-0254
pubmed: 28749772
Diallo MA, Badiane AS, Diongue K, Deme A, Lucchi NW, Gaye M, et al. Non-falciparum malaria in Dakar: a confirmed case of Plasmodium ovale wallikeri infection. Malar J. 2016;15:429.
doi: 10.1186/s12936-016-1485-1
pubmed: 27557982
pmcid: 4997729
Badiane AS, Diongue K, Diallo S, Ndongo AA, Diedhiou CK, Deme AB, et al. Acute kidney injury associated with Plasmodium malariae infection. Malar J. 2014;13:226.
doi: 10.1186/1475-2875-13-226
pubmed: 24906879
pmcid: 4062646
Diallo MA, Diongue K, Diagne G, Seck MC, Ndiaye M, Dièye B, et al. Le paludisme à Plasmodium ovale wallikeri et Plasmodium ovale curtisi au Sénégal en 2016 [Plasmodium ovale wallikeri and Plasmodium ovale curtisi Malaria in Senegal in 2016]. Bull Soc Pathol Exot. 2017;110:286–90.
doi: 10.1007/s13149-017-0578-6
pubmed: 29127650
Kotepui M, Kotepui KU, Milanez GD, Msangkay FR. Global prevalence and mortality of severe Plasmodium malariae infection: a systematic review and meta-analysis. Malar J. 2020;19:274.
doi: 10.1186/s12936-020-03344-z
pubmed: 32736635
pmcid: 7395392
Roucher C, Rogier C, Sokhna C, Tall A, Trape JF. A 20-year longitudinal study of Plasmodium ovale and Plasmodium malariae prevalence and morbidity in a West African population. PLoS ONE. 2014;9: e87169.
doi: 10.1371/journal.pone.0087169
pubmed: 24520325
pmcid: 3919715
Chenet SM, Schneider KA, Villegas L, Escalante AA. Local population structure of Plasmodium: impact on malaria control and elimination. Malar J. 2012;11:412.
doi: 10.1186/1475-2875-11-412
pubmed: 23232077
pmcid: 3538601
Nkhoma SC, Nair S, Al-Saai S, Ashley E, McGready R, Phyo AP, et al. Population genetic correlates of declining transmission in a human pathogen. Mol Ecol. 2013;22:273.
doi: 10.1111/mec.12099
pubmed: 23121253
Akala HM, Watson OJ, Mitei KK, Juma DW, Verity R, Ingasia LA, et al. Plasmodium interspecies interactions during a period of increasing prevalence of Plasmodium ovale in symptomatic individuals seeking treatment: an observational study. Lancet Microbe. 2021;2: e141.
doi: 10.1016/S2666-5247(21)00009-4
pubmed: 35544189
pmcid: 7613221
Taylor SM, Messina JP, Hand CC, Juliano JJ, Muwonga J, Tshefu AK, et al. Molecular malaria epidemiology: mapping and burden estimates for the Democratic Republic of the Congo, 2007. PLoS ONE. 2011;6: e16420.
doi: 10.1371/journal.pone.0016420
pubmed: 21305011
pmcid: 3031549
Black J, Hommel M, Snounou G, Pinder M. Mixed infections with Plasmodium falciparum and P malariae and fever in malaria. Lancet. 1994;343:1095.
doi: 10.1016/S0140-6736(94)90203-8
pubmed: 7909108
Daniels R, Chang HH, Sene PD, Park DC, Neafsey DE, Schaffner SF, et al. Genetic surveillance detects both clonal and epidemic transmission of malaria following enhanced intervention in Senegal. PLoS ONE. 2013;8: e60780.
doi: 10.1371/journal.pone.0060780
pubmed: 23593309
pmcid: 3617153
Hoffmann EH, da Silveira LA, Tonhosolo R, Pereira FJ, Ribeiro WL, Tonon AP, et al. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2. Ann Trop Med Parasitol. 2001;95:117.
doi: 10.1080/00034983.2001.11813622
pubmed: 11299119
Cowell AN, Valdivia HO, Bishop DK, Winzeler EA. Exploration of Plasmodium vivax transmission dynamics and recurrent infections in the Peruvian Amazon using whole genome sequencing. Genome Med. 2018;4(10):52.
doi: 10.1186/s13073-018-0563-0
Bulletin épidémiologique annuel 2021 du paludisme au Sénégal National Malaria Control Programme
Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833–40.
doi: 10.1038/nrmicro3364
pubmed: 25329408
Cheng Q, Cunningham J, Gatton ML. Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors. PLoS Negl Trop Dis. 2015;9: e3413.
doi: 10.1371/journal.pntd.0003413
pubmed: 25569135
pmcid: 4288718
Coalson JE, Walldorf JA, Cohee LM, Ismail MD, Mathanga D, Cordy RJ, et al. High prevalence of Plasmodium falciparum gametocyte infections in school-age children using molecular detection: patterns and predictors of risk from a cross-sectional study in southern Malawi. Malar J. 2016;15:527.
doi: 10.1186/s12936-016-1587-9
pubmed: 27809907
pmcid: 5096312
Cohee L, Laufer M. Tackling malaria transmission in sub-Saharan Africa. Lancet Glob Health. 2018;6: e598.
doi: 10.1016/S2214-109X(18)30197-9
pubmed: 29661636
pmcid: 6375073
Touray AO, Mobegi VA, Wamunyokoli F, Butungi H, Herren JK. Prevalence of asymptomatic P. falciparum gametocyte carriage among school children in Mbita, Western Kenya and assessment of the association between gametocyte density, multiplicity of infection and mosquito infection prevalence. Wellcome Open Res. 2021;5:259.
doi: 10.12688/wellcomeopenres.16299.2
pubmed: 33959684
pmcid: 8078214
Brenier-Pinchart MP, Pinel C, Croisonnier A, Brion JP, Faure O, Ponard D. Diagnosis of malaria in non-endemic countries by the Parasight-F test. Am J Trop Med Hyg. 2000;63:150.
doi: 10.4269/ajtmh.2000.63.150
pubmed: 11388507
Gamboa D, Ho MF, Bendezu J, Torres K, Chiodini PL, Barnwell JW, et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoSONE. 2010;5: e8091.
doi: 10.1371/journal.pone.0008091